Abstract
Background:
S100B is a well-established biomarker of central nervous system (CNS) development and damage in the perinatal period. Because the fetal CNS induces an overproduction of S100B measurable in the maternal bloodstream we evaluated S100B protein in healthy pregnancies in order to provide a reference curve of the protein in the second and third trimesters and to provide information on CNS development when standard monitoring procedures could be silent or unavailable.
Methods:
Between July 2012 and December 2014 we conducted a prospective study in 1213 healthy pregnancies delivering healthy newborns. Maternal blood samples were collected for standard monitoring procedures and S100B assessment. S100B correlations with selected outcomes (gestational age at sampling, gender of fetus, gestational age and weight at birth, delivery mode) were calculated using multiple forward stepwise regression analysis.
Results:
S100B concentrations in the second and third trimesters of pregnancy were found to be gestational age-, gender- and delivery mode-dependent (p<0.05, for all). Multiple forward stepwise regression analysis with S100B as the dependent variable and gestational age at sampling, gender, delivery mode, gestational age and weight at birth as independent variables, showed a significant correlation between S100B and gestational age at sampling (R=0.13; p<0.001).
Conclusions:
The present findings offering a S100B protein reference curve in maternal blood suggest that non-invasive fetal CNS monitoring is becoming feasible and open the way to further research in neuro-biomarker assessment in the maternal bloodstream.
Acknowledgments
This work is part of the I.O. PhD International Program under the auspices of the Italian Society of Neonatology and was partially supported by grants to DG from “I Colori della Vita Foundation”, Italy. We thank Diasorin, Saluggia, Italy, for supporting analysis kits.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Hagberg H, Mallard C. Antenatal brain injury: aetiology and possibilities of prevention. Semin Neonatol 2000;5:41–51.10.1053/siny.1999.0114Search in Google Scholar PubMed
2. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet Neonatal Survival Steering Team. Lancet 2005;365:891–900.10.1016/S0140-6736(05)71048-5Search in Google Scholar PubMed
3. Huang CC, Wang ST, Chang YC, Lin KP, Wu PL. Measurement of the urinary lactate: creatinine ratio for the early identification of newborn infants at risk from hypoxic-ischemic encephalopathy. N Engl J Med 1999;341:328–35.10.1056/NEJM199907293410504Search in Google Scholar PubMed
4. Gazzolo D, Abella R, Marinoni E, Di Iorio R, Livolti G, Galvano F, et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22:57–61.10.1080/14767050903181468Search in Google Scholar PubMed
5. Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero LD, et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644–59.10.1111/j.1471-4159.2011.07612.xSearch in Google Scholar PubMed
6. Gazzolo D, Abella R, Frigiola A, Giamberti A, Tina G, Nigro F, et al. Neuromarkers and unconventional biological fluids. J Matern Fetal Neonatal Med 2010;23:66–9.10.3109/14767058.2010.507960Search in Google Scholar PubMed
7. van Wezel-Meijler G, Steggerda SJ, Leijser LM. Cranial ultrasonography in neonates: role and limitations. Semin Perinatol 2010;34:28–38.10.1053/j.semperi.2009.10.002Search in Google Scholar PubMed
8. Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003;21:2108–97.Search in Google Scholar
9. Gazzolo D, Grutzfeld D, Michetti F, Toesca A, Lituania M, Bruschettini M, et al. Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem Lab Med 2004;50:941–4.10.1373/clinchem.2003.021048Search in Google Scholar PubMed
10. Gazzolo D, Di Iorio R, Marinoni E, Masetti P, Serra G, Giovannini L, et al. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002;30:1356–60.10.1097/00003246-200206000-00037Search in Google Scholar PubMed
11. Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M, et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med 2003;157:1163–8.10.1001/archpedi.157.12.1163Search in Google Scholar PubMed
12. Gazzolo D, Bruschettini M, Lituania M, Serra G, Bonacci W, Michetti F. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem Lab Med 2001;47:1836–8.10.1093/clinchem/47.10.1836Search in Google Scholar
13. Florio P, Michetti F, Bruschettini M, Lituania M, Bruschettini P, Severi FM, et al. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet 2004;364:270–2.10.1016/S0140-6736(04)16677-4Search in Google Scholar PubMed
14. Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M, et al. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 2004;32:131–6.10.1097/01.CCM.0000104116.91462.CDSearch in Google Scholar PubMed
15. Gazzolo D, Frigiola A, Bashir M, Iskander I, Mufeed H, Aboulgar H, et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One 2009;4:e4298.10.1371/journal.pone.0004298Search in Google Scholar PubMed PubMed Central
16. Gazzolo D, Vinesi P, Marinoni E, Di Iorio R, Marras M, Lituania M, et al. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem 2000;46:998–1000.10.1093/clinchem/46.7.998Search in Google Scholar PubMed
17. Gazzolo D, Bruschettini M, Lituania M, Serra G, Gandullia E, Michetti F. S100B protein in urine is correlated with gestational age in healthy preterm and term newborns. Clin Chem Lab Med 2001;47:1132–3.10.1093/clinchem/47.6.1132Search in Google Scholar
18. Gazzolo D, Lituania M, Bruschettini M, Ciotti S, Sacchi R, Serra G, et al. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 2005;38:229–33.10.1016/j.clinbiochem.2004.12.006Search in Google Scholar PubMed
19. Douglas-Escobar M, Weiss MD. Biomarkers of hypoxic-ischemic encephalopathy in newborns. Front Neurol 2012;3:144–6.10.3389/fneur.2012.00144Search in Google Scholar PubMed PubMed Central
20. Gazzolo D, Marinoni E, Di Iorio R, Lituania M, Marras M, Bruschettini M, et al. High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage. Clin Chem 2006;52:819–26.10.1373/clinchem.2005.060665Search in Google Scholar PubMed
21. Sannia A, Zimmermann LJ, Gavilanes AW, Vles HJ, Serpero LD, Frulio R, et al. S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta 201;412:1337–40.10.1016/j.cca.2011.03.034Search in Google Scholar PubMed
22. Leslie WD, Greenberg ID. Reference range determination: the problem of small sample sizes. J Nucl Med 1991;32:2306–10.Search in Google Scholar PubMed
23. Campbell S, Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynecol 2000;182:650–4.10.1111/j.1471-0528.1977.tb12550.xSearch in Google Scholar
24. Gazzolo D, Bruschettini M, Corvino V, Oliva R, Sarli R, Lituania M, et al. S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem 2001;47:954–6.10.1093/clinchem/47.5.954Search in Google Scholar PubMed
25. Sannia A, Risso FM, Zimmermann LJ, Gavilanes AW, Vles HJ, Gazzolo D. S100B urine concentrations in late preterm infants are gestational age and gender dependent. Clin Chim Acta 2013;417:31–4.10.1016/j.cca.2012.12.013Search in Google Scholar PubMed
26. Engle WA, Tomashek KM, Wallman C, Committee on Fetus and Newborn, American Academy of Pediatrics. Late-preterm infants: a population at risk. Pediatrics 2007;120:1390–401.10.1542/peds.2007-2952Search in Google Scholar
27. Kapural M, Krizanac-Bengez Lj, Barnett G, Perl J, Masaryk T, Apollo D, et al. SerumS-100beta as a possible marker of blood-brain barrier disruption. Brain Res 2002;940:102–4.10.1016/S0006-8993(02)02586-6Search in Google Scholar
28. Marinoni E, Di Iorio R, Gazzolo D, Lucchini C, Michetti F, Corvino V, et al. Ontogenetic localization and distribution of S-100beta protein in human placental tissues. Obstet Gynecol 2002;99:1093–9.10.1097/00006250-200206000-00025Search in Google Scholar PubMed
29. Gazzolo D, Marinoni E, di Iorio R, Lituania M, Bruschettini PL, Michetti F. Circulating S100-beta protein is increased in intrauterine growth-retarded fetuses. Pediatr Res 2002;51:215–9.10.1203/00006450-200202000-00015Search in Google Scholar PubMed
30. Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-a and S100-b proteins in normal nonnervous human tissues. Lab Invest 1987;57:489–98.Search in Google Scholar
31. Negri-Cesi P, Colciago A, Celotti F, Motta M. Sexual differentiation of the brain: role of testosterone and its active metabolites. J Endocrinol Invest 2004;27:120–7.Search in Google Scholar PubMed
32. Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, et al. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin Chem 2003;49:967–70.10.1373/49.6.967Search in Google Scholar PubMed
33. Haynes RL, Borenstein NS, De Silva TM, Folkerth RD, Liu LG, Volpe JJ, et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 2005;484:156–67.10.1002/cne.20453Search in Google Scholar PubMed
34. Huppi PS, Warfield S, Kikinis R, Barnes PD, Zientara GP, Jolesz FA, et al. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 1998;43:224–35.10.1002/ana.410430213Search in Google Scholar PubMed
35. Schulpis KH, Margeli A, Akalestos A, Vlachos GD, Partsinevelos GA, Papastamataki M, et al. Effects of mode of delivery on maternal-neonatal plasma antioxidant status and on protein S100B serum concentrations. Scand J Clin Lab Invest 2006;66:733–42.10.1080/00365510600977737Search in Google Scholar PubMed
36. Thorngren-Jerneck K, Alling C, Herbst A, Amer-Wahlin I, Marsal K. S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2004;55:406–12.10.1203/01.PDR.0000106806.75086.D3Search in Google Scholar PubMed
37. Garnier Y, Frigiola A, Li Volti G, Florio P, Frulio R, Berger R, et al. Increased maternal/fetal blood S100B levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Reprod Sci 2009;16:758–66.10.1177/1933719109335801Search in Google Scholar PubMed
38. Giussani DA, Thakor AS, Frulio R, Gazzolo D. Acute hypoxia increases S100beta protein in association with blood flow redistribution away from peripheral circulations in fetal sheep. Pediatr Res 2005;58:179–84.10.1203/01.PDR.0000169999.66157.C0Search in Google Scholar PubMed
39. Vannuccini S, Bocchi C, Severi FM, Challis JR, Petraglia F. Endocrinology of human parturition. Ann Endocrinol (Paris) 2016;77:105–13.10.1016/j.ando.2016.04.025Search in Google Scholar PubMed
40. Bellissima V, Visser GH, Ververs TF, van Bel F, Termote JU, van Heide M, et al. Antenatal maternal antidepressants drugs affect s100b concentrations in fetal-maternal biological fluids. CNS Neurol Disord Drug Targets 2015;14:49–54.10.2174/1871527314666150116114033Search in Google Scholar PubMed
41. Gazzolo D, Bruschettini M, Di Iorio R, Marinoni E, Lituania M, Marras M, et al. Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses. Clin Chem 2002;48:647–50.10.1093/clinchem/48.4.647Search in Google Scholar PubMed
42. Gazzolo D, Kornacka M, Bruschettini M, Lituania M, Giovannini L, Serra G, et al. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem 2003;49:1215–8.10.1373/49.7.1215Search in Google Scholar PubMed
43. Sannia A, Risso FM, Serpero LD, Frulio R, Michetti F, Abella R, et al. Antenatal glucocorticoid treatment affects preterm infants’ S100B urine concentration in a dose-dependent manner. Clin Chim Acta 2010;411:1539–41.10.1016/j.cca.2010.05.045Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
